abstract |
The present invention relates to a novel 3,4-dihydro-lH-naphthalenenderivative having a structurenof formula 1 or formula 2, its pharmaceuticallynacceptable salts and their geometric isomers as anhighly selective cyclooxygenase-2 inhibitor.n n n Wherein, R 1 , R 2 , X, A and Q are defined in thisnspecification respectively. |